ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,436.20
-0.10%
S&P ASX All Technology
3,964.00
0.35%
Brent Oil
71.98
-0.08%
US Dollar vs AUD
1.53421
-0.14%
Bitcoin
96,748.68
-0.76%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Boundless Bio Inc (BOLD)

  7. Boundless Bio Inc (BOLD) News

BOLD

Boundless Bio (BOLD)

Boundless Bio Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:BOLD
DateTimeSourceHeadlineSymbolCompany
25/11/202423:00GlobeNewswire Inc.Boundless Bio to Participate in the Piper Sandler Healthcare ConferenceNASDAQ:BOLDBoundless Bio Inc
08/11/202408:06Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BOLDBoundless Bio Inc
08/11/202408:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BOLDBoundless Bio Inc
08/11/202408:01GlobeNewswire Inc.Boundless Bio Reports Third Quarter 2024 Financial Results and Business HighlightsNASDAQ:BOLDBoundless Bio Inc
05/11/202423:00GlobeNewswire Inc.Boundless Bio to Participate in the 2024 Guggenheim Global Healthcare ConferenceNASDAQ:BOLDBoundless Bio Inc
15/10/202423:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BOLDBoundless Bio Inc
14/10/202423:00GlobeNewswire Inc.Boundless Bio Announces Departure of Chief Financial OfficerNASDAQ:BOLDBoundless Bio Inc
11/09/202421:00GlobeNewswire Inc.Boundless Bio to Participate in the 2024 Cantor Global Healthcare ConferenceNASDAQ:BOLDBoundless Bio Inc
21/08/202409:03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BOLDBoundless Bio Inc
21/08/202407:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BOLDBoundless Bio Inc
13/08/202406:25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BOLDBoundless Bio Inc
13/08/202406:10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BOLDBoundless Bio Inc
13/08/202406:01GlobeNewswire Inc.Boundless Bio Provides Business Updates Focused on Key Value Drivers and Reports Second Quarter 2024 Financial ResultsNASDAQ:BOLDBoundless Bio Inc
05/06/202421:00Business WireBoundless Bio to Participate in the Goldman Sachs 45th Annual Global Healthcare ConferenceNASDAQ:BOLDBoundless Bio Inc
13/05/202421:06Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BOLDBoundless Bio Inc
13/05/202421:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BOLDBoundless Bio Inc
13/05/202421:00Business WireBoundless Bio Reports First Quarter 2024 Financial Results and Corporate HighlightsNASDAQ:BOLDBoundless Bio Inc
06/05/202422:00Business WireBoundless Bio to Present at the Citizens JMP Life Sciences Conference 2024NASDAQ:BOLDBoundless Bio Inc
11/04/202422:00Business WireBoundless Bio Announces First Patient Dosed in First-in-Human Phase 1/2 Clinical Trial of BBI-825 in Cancer Patients with Resistance Gene AmplificationsNASDAQ:BOLDBoundless Bio Inc
08/04/202422:00Business WireBoundless Bio Presents Preclinical and Clinical Pharmacodynamic Data on its Lead Extrachromosomal DNA (ecDNA)-Directed Therapy, BBI-355, at the American Association for Cancer Research Annual Meeting 2024NASDAQ:BOLDBoundless Bio Inc
15/02/202009:23Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:BOLDBoundless Bio Inc
15/02/202008:35Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:BOLDBoundless Bio Inc
15/02/202008:15Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:BOLDBoundless Bio Inc
12/02/202008:41Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:BOLDBoundless Bio Inc
06/02/202003:27Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:BOLDBoundless Bio Inc
28/01/202001:38Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:BOLDBoundless Bio Inc
21/01/202022:00Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:BOLDBoundless Bio Inc
21/01/202022:00Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:BOLDBoundless Bio Inc
04/12/201911:13PR Newswire (US)SHAREHOLDER ALERT: WeissLaw LLP Investigates Audentes Therapeutics, Inc.NASDAQ:BOLDBoundless Bio Inc
03/12/201910:01Business WireAstellas Enters into Definitive Agreement to Acquire Audentes TherapeuticsNASDAQ:BOLDBoundless Bio Inc
 Showing the most relevant articles for your search:NASDAQ:BOLD

Your Recent History

PM
XAUUSD
Gold vs US Dollar
ASX
RIO
Rio Tinto
ASX
XJO
S&P ASX 200
NYSE
NKE
Nike
NYSE
JPM
JP Morgan Chase
CCOM
SILVER
SILVER
ASX
ANZ
Australia And New Zealan...
FX
AUDCAD
AUD vs CAD
SPI
SP500
S&P 500
ASX
TLS
Telstra
ASX
WES
Wesfarmers
ASX
WBC
Westpac Banking
ASX
XFL
S&P ASX 50
FX
AUDJPY
AUD vs Yen
NASDAQ
AMZN
Amazon.com
ASX
WPL
Woodside Petroleum
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 60%* for ASX Level 1 & 2

1 year 40%, 2 years 40% and *3 years 60%

*Across 3 years $1958.40 only $783.36